Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit
As Cargo Therapeutics looks for a permanent solution to its troubles, the biotech is dropping its remaining clinical programs and laying off the majority of staff in a second round of cuts in recent months ...
